U.S. Patent Disclosures
Wednesday, January 19, 2011
Omni Bio Pharmaceutical Inc., of Denver, has received U.S. Patent No. 7,807,781 titled "Inhibitors of Serine Protease Activity and Their Use in Methods and Compositions for Treatment of Viral Infections."
Sign up for Perspectives FREE e-mail newsletter.
Outside the U.S.: 1-404-262-5476
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Copyright @ 2013 AHC Media. Reproduction, reposting content is strictly prohibited.